DISEASE INDICATIONS: Migraine

MANUFACTURER: Amgen Inc. / Novartis Pharmaceuticals Corporation

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Pharmaceuticals and Medical Devices Agency (PMDA)

Therapeutic Goods Administration (TGA)

Swissmedic (CH)

Medsafe (NZ)

Aimovig (erenumab) is a medication approved by the Food and Drug Administration (FDA) for the prevention of episodic or chronic migraines.